UNSPSC 51412003: Butalamine hydrochloride

This classification denotes a vasodilating agent with the molecular formula C18H28N4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 140T9JTG43, chemically known as 1,2-ethanediamine, n,n-dibutyl-n-(3-phenyl-1,2,4-oxadiazol-5-yl)- but generally known as butalamine, which bears US NIH Compound Identifier 30949. Butalamine most often comes in base and hydrochloride forms. European Medicines Agency schedules Butalamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05998MIG.

UNSPSC 51412003 Butalamine hydrochloride is a Commodity code covering specific pharmaceutical products used in emergency medical response. State and local governments procure medications under this code for fire rescue departments, emergency medical services, and related public-health agencies. The Tampa Fire Rescue procurement illustrates the actual scope: sealed-bid solicitations for advanced life support medications including vasopressors, inotropes, and antiarrhythmics supplied in vial or injectable form, with strict expiration-dating, warranty, and chain-of-custody requirements. Issuing bodies include city purchasing departments managing fire and rescue operations; the code sees activity primarily among municipal fire departments and EMS agencies rather than county or state health departments.

Recent activity concentrates in Florida. The City of Tampa issued IFB 26P00188 on April 24, 2026, for advanced life support medications (Labetalol, Epinephrine, Adenosine, and Diltiazem) with a response deadline of April 8, 2026, and an estimated contract value of $40,000.00. The solicitation carried a Small Local Business Enterprise sheltered market designation with a five-percent bid discount not to exceed $10,000, required Safety Data Sheets compliant with OSHA standards, and a one-year initial term with two one-year renewal options plus up to three additional 30-day extensions at the City's discretion. Delivery was required within ten calendar days of order receipt, and all medications had to maintain a nine-month minimum expiration date from acceptance.